Patents by Inventor Lendon Payne

Lendon Payne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
    Publication number: 20070237789
    Abstract: Methods of eliciting an immune response in a subject by administering one or more large genomic DNA fragments are provided. Also provided are methods of identifying sequences encoding antigenic polypeptides. Also provided are vaccine compositions comprising one or more large genomic DNA fragments.
    Type: Application
    Filed: March 14, 2007
    Publication date: October 11, 2007
    Inventors: William Swain, Lee Roberts, Lendon Payne, Ralph Braun
  • HIV-1 prophylactic composition and method
    Patent number: 5891444
    Abstract: A composition and method for inducing a protective immune response to HIV-1 in an individual, of (a) a replication incompetent HIV-1, HIV-1 pseudovirus, HIV-1 VLP or oligomeric gp120; and (b) a water soluble polyphosphazene polyelectrolyte, wherein (a) and (b) are present in an amount effective to induce a protective immune response against HIV-1.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 6, 1999
    Assignee: Virus Research Institute, Inc.
    Inventors: Sharon Jenkins, Yichen Lu, Lendon Payne, Bryan Roberts
  • Self-assembling replication defective hybrid virus particles
    Patent number: 5858726
    Abstract: The invention pertains to self-assembled replication defective hybrid virus-like particles having capsid and membrane glycoproteins from at least two different virus types and method of making same. Recombinant viral vectors as well as the viral particles can be used as immunogens and drug delivery vehicles.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: January 12, 1999
    Assignee: Therion Biologics
    Inventor: Lendon Payne
  • Self-assembling replication defective hybrid virus particles
    Patent number: 5420026
    Abstract: The invention pertains to self-assembled replication defective hybrid virus-like particles having capsid and membrane glycoproteins from at least two different virus types and method of making same. Recombinant viral vectors as well as the viral particles can be used as immunogens and drug delivery vehicles.
    Type: Grant
    Filed: February 12, 1993
    Date of Patent: May 30, 1995
    Assignee: Therion Biologics Corporation
    Inventor: Lendon Payne